DOCSLIB.ORG

(12) Patent Application Publication (10) Pub. No.: US 2010/0323402 A1 Ono Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

US 201003234O2A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2010/0323402 A1 Ono et al. (43) Pub. Date: Dec. 23, 2010 (54) UDP-GLUCURONYL TRANSFERASE AND Publication Classification POLYNUCLEOTDE ENCODING THE SAME (51) Int. Cl. CI2P 9/60 (2006.01) (75) Inventors: Eiichiro Ono, Osaka (JP); Akio C7H 2L/04 (2006.01) Noguchi, Osaka (JP); Yuko Fukui, C7H 2L/00 (2006.01) Osaka (JP); Masako Mizutani, CI2N 9/10 (2006.01) Osaka (JP) CI2N 15/63 (2006.01) CI2N I/2 (2006.01) Correspondence Address: (52) U.S. Cl. ......... 435/75:536/23.2:536/23.1; 435/193; GREENBLUM & BERNSTEIN, P.L.C. 1950 ROLAND CLARKE PLACE 435/320.1; 435/252.33 RESTON, VA 20191 (US) (57) ABSTRACT The present invention provides a novel UDP-glucuronosyl (73) Assignee: SUNTORY HOLDINGS transferase and a polynucleotide encoding the same (for LIMITED, Osaka (JP) example, a polynucleotide comprising a polynucleotide con sisting of one nucleotide sequence selected from the group (21) Appl. No.: 12/678,161 consisting of the nucleotide sequence at positions 1 to 1359 in the nucleotide sequence represented by SEQ ID NO: 4, the (22) PCT Fled: Sep. 29, 2008 nucleotide sequence at positions 1 to 1365 in the nucleotide PCT NO.: PCT/UP2008/O67613 sequence represented by SEQ ID NO: 10, the nucleotide (86) sequence at positions 1 to 1371 in the nucleotide sequence S371 (c)(1), represented by SEQID NO: 12, and the nucleotide sequence (2), (4) Date: May 12, 2010 at positions 1 to 1371 in the nucleotide sequence represented by SEQ ID NO: 22; or a polynucleotide comprising a poly (30) Foreign Application Priority Data nucleotide encoding a protein having one amino acid sequence selected from the group consisting of SEQID NOS: Oct. 12, 2007 (JP) ................................. 2007-267050 5, 11, 13 and 23), etc. This provides a novel UDP-glucurono Mar 17, 2008 (JP) ................................. 2008-067.185 syltransferase with a broad substrate specificity. Patent Application Publication Dec. 23, 2010 Sheet 1 of 8 US 2010/0323402 A1 Formatted Alignments AmUGTogi Oaa 450 SEUGTaa 448 445 434 Patent Application Publication Dec. 23, 2010 Sheet 2 of 8 US 2010/0323402 A1 Fig. 2 BaiCalein a SCutellarein a Apigenin a Luteolin TriCetin DiOSmetin 3.33. Chrysoeriol is Vitexin ISOVitexin Orientin Kaempferol QuerCetin Myricetins Naringenin AureuSidin Genistein DaidZein Formononetin Catechin Epigallocatechin gallate ESCuletin Coniferyl alcohol ReSVeratrol SC1 SC2 Relative activity (%) Patent Application Publication Dec. 23, 2010 Sheet 3 of 8 US 2010/0323402 A1 Fig. 3 BaiCalein SCutellarein Apigenin Luteolin TriCetin DiOSmetin Chrysoeriol Vitexin SOVitexin Orientin Kaempferol QuerCetin Naringenin AureuSidin Genistein Daidzein Formononetin Catechin Epigallocatechin gallate ESCulletin Coniferyl alcohol ReSVeratrol SC 1 SC2 EC2 O 20 40 60 80 100 120 Relative activity (%) Patent Application Publication Dec. 23, 2010 Sheet 4 of 8 US 2010/0323402 A1 Baicalein SCutellarein Apigenin Luteolin TriCetin DiOSmetin Chrysoeriol Vitexin ISOVitexin Orientin Kaempferol QuerCetin Naringenin Aureusidin Genistein Daidzein Formononetin Catechin Epigallocatechin gallate ESCulletin Coniferyl alcohol ReSVeratrol SC1 SC2 EC2 O 20 40 60 80 100 120 Relative activity (%) Patent Application Publication Dec. 23, 2010 Sheet 5 of 8 US 2010/0323402 A1 Fig. 5 BaiCalein SCutellarein Apigenin Luteolin TriCetin DioSmetin Chrysoeriol Vitexin SOVitexin Orientin Kaempferol QuerCetin Naringenin AureuSidin Genistein DaidZein Formononetin Catechin Epigallocatechin gallate ESCulletin Caffeic acid Resveratrol SC1 SC2 EC2 O 20 40 60 80 100 120 Relative activity (%) Patent Application Publication Dec. 23, 2010 Sheet 6 of 8 US 2010/0323402 A1 Fig. 6 0.0 2.5 5. O 7.5 10.0 2.5 15.0 min Patent Application Publication Dec. 23, 2010 Sheet 7 of 8 US 2010/0323402 A1 Fig. 7 s 3 & 3 Patent Application Publication Dec. 23, 2010 Sheet 8 of 8 US 2010/0323402 A1 1z'g'''. g as sus or narrarass guns in a na narran sesssssssssssssserraneant ?cosit/ Trainiere S '' i i is is elziz (i. st is a i E use E S35 :: US 2010/0323402 A1 Dec. 23, 2010 UDP-GLUCURONYLTRANSFERASE AND is registered in GenBank (Accession No. AB042277) but its POLYNUCLEOTIDE ENCODING THE SAME function remains unconfirmed. 0008. On the other hand, it is known that flavone 7-glucu FIELD OF THE INVENTION ronides which are more diverse than skullcap or “wogon' are accumulated in Perilla frutescens a red-leaf variety with a 0001. The present invention relates to a UDP-glucurono dietary experience (Literature 7: Yamazaki, M. et al. Phy Syltransferase, a polynucleotide encoding the same, a vector tochemistry 62,987-998. 2003). containing the same, a transformant, and so on. Literatures: BACKGROUND OF THE INVENTION 0009. 1. Day, A. J. et al., Free Radic. Res., 35,941-952, 0002 Polyphenolic plant secondary metabolites including 2001 flavonoids and lignans with a rich dietary experience have (0010 2. Moon, J. H. et al., Free Radical Biology & Medi attracted attention as functional materials over the years due cine, 30, 1274-1285, 2001 to their functional properties represented by their antioxida 0011 3. O'Leary, K. A. et al., Biochemical Pharmacology, tive activities, and are already commercially available as 65, 479–491, 2003 health foods. For example, quercetin (flavonoid), OTPP (fla 0012 4. Vander Woude, H. et al., Chem. Res. Toxicol., 17, vonoid), Sesamin (lignan), etc. are representative materials 1520-1530, 2004 for health foods. 0013 5. Gao, Z. et al., Biochemica et Biophysica Acta, 0003. The biosynthetic pathway of flavonoids in plant 1472, 643-650, 1999 cells has been studied since old times. Biosynthetic enzymes (0014) 6. Nagashima S. et al., Phytochemistry, 53,533-538, that catalyze the metabolic pathway and genes encoding the 2OOO. enzymes are isolated, leading to a better understanding of (0015 7. Yamazaki, M. et al., Phytochemistry, 62.987-998, their molecular mechanisms. 2003 0004. On the other hand, knowledge is insufficient on how the plant secondary metabolites would be metabolized to DISCLOSURE OF THE INVENTION exhibit their functions, after their in vivo uptake. 0005. It is known that glycosylation of plant secondary Problems To Be Solved by the Invention metabolites is generally catalyzed by an enzyme belonging to 0016 Under these circumstances, it has been desired to the superfamily called UDP-glycosyltransferase (UGT), irre identify a novel UDP-glucuronosyltransferase having a spective of types of Sugars (glucose, rhamnose, glucuronic broader Substrate specificity and a gene encoding the same. acid, galactose, etc.). Further in the studies of Sesamin, the secondary metabolites are shown to be present in vivo as Means of Solving the Problem glucuronides via catechol metabolites. It is thus considered that the glucuronides would play a part in developing the in 0017. The present invention has been made in view of the Vivo functions of plant secondary metabolites. foregoing circumstances and provides the following UDP 0006. It is confirmed that four monoglucuronides are glucuronosyltransferases and polynucleotides encoding the present as the metabolites of quercetin in mammals (Q-3- same, as well as vectors bearing the same, transformants, and GlcA, Q-7-GlcA, Q-3'-GlcA and Q-4'-GlcA) (Literature 1: SO. O. Day, AJ et al. Free Radic. Res. 35,941-952, 2001, Literature 0018 (1) A polynucleotide of any one of (a) through (f) 2: Moon, J. H. et al. Free Radical Biology & Medicine 30, below: 1274-1285, 2001, Literature 3: O'Leary, K. A. et al. Bio 0019 (a) a polynucleotide comprising a polynucleotide chemical Pharmacology 65, 479–491, 2003, and Literature 4: consisting of one nucleotide sequence selected from the van der Woude, H. et al. Chem. Res. Toxicol. 17, 1520-1530, group consisting of the nucleotide sequence at positions 1 to 2004); in order to understand these functions in vivo, it is 1359 in the nucleotide sequence represented by SEQID NO: necessary to obtain a sufficient amount of compounds to 4, the nucleotide sequence at positions 1 to 1365 in the nucle examine their activities. However, any appropriate UDP-glu otide sequence represented by SEQID NO: 10, the nucleotide curonosyltransferase showing a broad Substrate specificity is sequence at positions 1 to 1371 in the nucleotide sequence unknown so far, and it was actually impossible to chemically represented by SEQID NO: 12, and the nucleotide sequence synthesize a binding site-specific reaction product. at positions 1 to 1371 in the nucleotide sequence represented 0007. The radix of Labiatae Scutellaria baicalensis is by SEQID NO: 22: called skullcap or “wogon' in Japanese, and it is known that 0020 (b) a polynucleotide comprising a polynucleotide 7-glucuronides of highly antioxidative flavones are accumu encoding a protein having one amino acid sequence selected lated therein. According to the borderline of pharmaceuticals from the group consisting of SEQID NOs: 5, 11, 13 and 23; to non-pharmaceuticals, the radix of Scutellaria baicalensis 0021 (c) a polynucleotide comprising a polynucleotide is classified into the pharmaceuticals (Literature 5: Gao, Z. et encoding a protein consisting of an amino acid sequence with al. Biochimica et Biophysica Acta 1472, 643-650. 1999). To deletion, substitution, insertion and/or addition of 1 to 15 date, Sb7GAT is purified from Labiatae Scutellaria baicallen amino acids in one amino acid sequence selected from the sis as flavone 7-glucuronosyltransferase; this enzyme acts group consisting of SEQID NOs: 5, 11, 13 and 23, and having only on flavones with Substituents such as hydroxyl group at a UDP-glucuronosyltransferase activity; the ortho position of the 7-OH flavones (baicalein, scutella 0022 (d) a polynucleotide comprising a polynucleotide rein, etc.) but does not act on apigenin and luteolin which are encoding a protein having an amino acid sequence having a the major flavones and further not on quercetin which is one homology of at least 80% to one amino acid sequence of flavonols (Literature 6: Nagashima S. et al., Phytochemis selected from the group consisting of SEQID NOs: 5, 11, 13 try 53,533-538, 2000).
Recommended publications
  • Antioxidant and Inhibition of Elastase Effect of Scutellarein and Apigenin

    Antioxidant and Inhibition of Elastase Effect of Scutellarein and Apigenin

    American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) ISSN (Print) 2313-4410, ISSN (Online) 2313-4402 © Global Society of Scientific Research and Researchers http://asrjetsjournal.org/ Antioxidant and Inhibition of Elastase Effect of Scutellarein and Apigenin Leo Tjermina*, I Nyoman Ehrich Listerb, Ali Napiah Nasutionc, Ermi Girsangd a,b,cFaculty of Medicine, University of Prima Indonesia, Medan, North Sumatera, Indonesia dFaculty of Public Health, University of Prima Indonesia, Medan, North Sumatera, Indonesia aEmail: [email protected] Abstract Aging process in the skin was begun from the time when one is born, especially skin. Cutaneous aging can be caused by intrinsic and/or extrinsic factors. Wrinkles, thinning, and roughening of skin are part of skin aging. It becomes important looking for natural sources to prevent aging process. Apigenin and Scutellarein are potential phytochemistry which have antioxidant and anti-elastase effects. The purpose of this study is investigate antioxidant and anti-elastase effects of Apigenin and Flavonoid. Determination of Antioxidant Activity of Apigenin and Scutellarien was using FRAP Methods while anti-elastase activity was determined by inhibition of Elastase from Porcine Pancreas. The result of this study was expressed by Mean ± SD and analyzed by One Way analysis of variance (ANOVA) and Turkey HSD Post Hoc Test as a Further Analysis. Both of Scutellarein or Apigenin had the most potent antioxidant activity at the highest concentration (50 µg/ml). The FRAP Activity of Scutellarein or Apigenin at Highest concentration are 250.22 ±2.3 and 29.05 ±5.88 µg Fe (II), respectively. Antioxidant activity of Scutellarein are more potent than apigenin at various concentration and was shown differences at P value < 0.05.
  • Characterization of C-Glycosidic Flavonoids from Brazilian Passiflora Species Using Lc/Ms Exact Mass Measurement

    Characterization of C-Glycosidic Flavonoids from Brazilian Passiflora Species Using Lc/Ms Exact Mass Measurement

    CHARACTERIZATION OF C-GLYCOSIDIC FLAVONOIDS FROM BRAZILIAN PASSIFLORA SPECIES USING LC/MS EXACT MASS MEASUREMENT 1 2 2 NOTE M. McCullagh , C.A.M. Pereira , J.H. Yariwake 1Waters Corporation, Floats Road, Wythenshawe, Manchester, M23 9LZ, UK 2Universidade de São Paulo, Instituto de Química de São Carlos, São Carlos, SP, Brazil OVERVIEW This application note describes the analysis of extracts Recently issues have arisen with Kava Kava, a natural from Passiflora species using real time centroid exact health product, which is used for its anti-depressant and mass measurement. The system used comprised of an anti-anxiety properties. Investigations into the safety of LCT™ orthogonal acceleration (oa-TOF) time of flight Kava have taken place within several European mass spectrometer with LockSpray™ source, Waters® countries, including Germany, U.K., Switzerland, 2996 PDA and Waters Alliance® HT 2795 France, Spain and parts of Scandinavia. In Switzerland Separations Module. and Germany cases of liver damage were reported. In Application the US the FDA has investigated Kava's safety, where INTRODUCTION as in Canada the public were advised not to take the EU Directive 2001/83/EC will regulate and produce a supplement until product safety could be assured. The set of harmonized assessment criteria for the efficacy Kava market in Germany alone is $25m. Proving the and safety "Herbal Medicinal Products for traditional efficacy of such a product is economically viable. use". The current and future E.U. member states will Such issues illustrate how regulation currently affects produce and abide by this directive, making 28 states the natural health product market and also why new in total.
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants

    The Phytochemistry of Cherokee Aromatic Medicinal Plants

    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
  • Shilin Yang Doctor of Philosophy

    Shilin Yang Doctor of Philosophy

    PHYTOCHEMICAL STUDIES OF ARTEMISIA ANNUA L. THESIS Presented by SHILIN YANG For the Degree of DOCTOR OF PHILOSOPHY of the UNIVERSITY OF LONDON DEPARTMENT OF PHARMACOGNOSY THE SCHOOL OF PHARMACY THE UNIVERSITY OF LONDON BRUNSWICK SQUARE, LONDON WC1N 1AX ProQuest Number: U063742 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest U063742 Published by ProQuest LLC(2017). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 ACKNOWLEDGEMENT I wish to express my sincere gratitude to Professor J.D. Phillipson and Dr. M.J.O’Neill for their supervision throughout the course of studies. I would especially like to thank Dr. M.F.Roberts for her great help. I like to thank Dr. K.C.S.C.Liu and B.C.Homeyer for their great help. My sincere thanks to Mrs.J.B.Hallsworth for her help. I am very grateful to the staff of the MS Spectroscopy Unit and NMR Unit of the School of Pharmacy, and the staff of the NMR Unit, King’s College, University of London, for running the MS and NMR spectra.
  • Phenolic Profiling of Veronica Spp. Grown in Mountain, Urban and Sand Soil Environments

    Phenolic Profiling of Veronica Spp. Grown in Mountain, Urban and Sand Soil Environments

    CORE Metadata, citation and similar papers at core.ac.uk Provided by Biblioteca Digital do IPB Phenolic profiling of Veronica spp. grown in mountain, urban and sand soil environments João C.M. Barreiraa,b,c, Maria Inês Diasa,c, Jelena Živkovićd, Dejan Stojkoviće, Marina Sokoviće, Celestino Santos-Buelgab,*, Isabel C.F.R. Ferreiraa,* aCIMO/Escola Superior Agrária, Instituto Politécnico de Bragança, Apartado 1172, 5301-855 Bragança, Portugal. bGIP-USAL, Facultad de Farmacia, Universidad de Salamanca, Campus Miguel de Unamuno, 37007 Salamanca, Spain. cREQUIMTE/Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, nº 228, 4050-313 Porto, Portugal. dInstitute for Medicinal Plant Research “Dr. Josif Pančić”, Tadeuša Košćuška 1, 11000 Belgrade, Serbia. eDepartment of Plant Physiology, Institute for Biological Research “Siniša Stanković”, University of Belgrade, Bulevar Despota Stefana 142, 11000 Belgrade, Serbia. * Authors to whom correspondence should be addressed (Isabel C.F.R. Ferreira; e-mail: [email protected], telephone +351273303219, fax +351273325405; e-mail: Celestino Santos- Buelga: [email protected]; telephone +34923294537; fax +34923294515). 1 Abstract Veronica (Plantaginaceae) genus is widely distributed in different habitats. Phytochemistry studies are increasing because most metabolites with pharmacological interest are obtained from plants. The phenolic compounds of V. montana, V. polita and V. spuria were tentatively identified by HPLC-DAD-ESI/MS. The phenolic profiles showed that flavones were the major compounds (V. montana: 7 phenolic acids, 5 flavones, 4 phenylethanoids and 1 isoflavone; V. polita: 10 flavones, 5 phenolic acids, 2 phenylethanoids, 1 flavonol and 1 isoflavone; V. spuria: 10 phenolic acids, 5 flavones, 2 flavonols, 2 phenylethanoids and 1 isoflavone), despite the overall predominance of flavones.
  • In Vitro Metabolism of Six C-Glycosidic Flavonoids from Passiflora Incarnata L

    In Vitro Metabolism of Six C-Glycosidic Flavonoids from Passiflora Incarnata L

    International Journal of Molecular Sciences Article In Vitro Metabolism of Six C-Glycosidic Flavonoids from Passiflora incarnata L. Martina Tremmel 1, Josef Kiermaier 2 and Jörg Heilmann 1,* 1 Department of Pharmaceutical Biology, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany; [email protected] 2 Department of Central Analytics, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany; [email protected] * Correspondence: [email protected] Abstract: Several medical plants, such as Passiflora incarnata L., contain C-glycosylated flavonoids, which may contribute to their efficacy. Information regarding the bioavailability and metabolism of these compounds is essential, but not sufficiently available. Therefore, the metabolism of the C-glycosylated flavones orientin, isoorientin, schaftoside, isoschaftoside, vitexin, and isovitexin was investigated using the Caco-2 cell line as an in vitro intestinal and epithelial metabolism model. Isovitexin, orientin, and isoorientin showed broad ranges of phase I and II metabolites containing hy- droxylated, methoxylated, and sulfated compounds, whereas schaftoside, isoschaftoside, and vitexin underwent poor metabolism. All metabolites were identified via UHPLC-MS or UHPLC-MS/MS using compound libraries containing all conceivable metabolites. Some structures were confirmed via UHPLC-MS experiments with reference compounds after a cleavage reaction using glucuronidase and sulfatase. Of particular interest is the observed cleavage of the C–C bonds between sugar and aglycone residues in isovitexin, orientin, and isoorientin, resulting in unexpected glucuronidated or sulfated luteolin and apigenin derivatives. These findings indicate that C-glycosidic flavones can be Citation: Tremmel, M.; Kiermaier, J.; highly metabolized in the intestine.
  • Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times

    Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times

    Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Traditional Herbal Medicines for Modern Times Each volume in this series provides academia, health sciences, and the herbal medicines industry with in-depth coverage of the herbal remedies for infectious diseases, certain medical conditions, or the plant medicines of a particular country. Series Editor: Dr. Roland Hardman Volume 1 Shengmai San, edited by Kam-Ming Ko Volume 2 Rasayana: Ayurvedic Herbs for Rejuvenation and Longevity, by H.S. Puri Volume 3 Sho-Saiko-To: (Xiao-Chai-Hu-Tang) Scientific Evaluation and Clinical Applications, by Yukio Ogihara and Masaki Aburada Volume 4 Traditional Medicinal Plants and Malaria, edited by Merlin Willcox, Gerard Bodeker, and Philippe Rasoanaivo Volume 5 Juzen-taiho-to (Shi-Quan-Da-Bu-Tang): Scientific Evaluation and Clinical Applications, edited by Haruki Yamada and Ikuo Saiki Volume 6 Traditional Medicines for Modern Times: Antidiabetic Plants, edited by Amala Soumyanath Volume 7 Bupleurum Species: Scientific Evaluation and Clinical Applications, edited by Sheng-Li Pan Traditional Herbal Medicines for Modern Times Herbal Principles in Cosmetics Properties and Mechanisms of Action Bruno Burlando, Luisella Verotta, Laura Cornara, and Elisa Bottini-Massa Cover art design by Carlo Del Vecchio. CRC Press Taylor & Francis Group 6000 Broken Sound Parkway NW, Suite 300 Boca Raton, FL 33487-2742 © 2010 by Taylor and Francis Group, LLC CRC Press is an imprint of Taylor & Francis Group, an Informa business No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-13: 978-1-4398-1214-3 (Ebook-PDF) This book contains information obtained from authentic and highly regarded sources.
  • Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study

    Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study

    RESEARCH ARTICLE Revisiting Greek Propolis: Chromatographic Analysis and Antioxidant Activity Study Konstantinos M. Kasiotis1*, Pelagia Anastasiadou1, Antonis Papadopoulos2, Kyriaki Machera1* 1 Benaki Phytopathological Institute, Department of Pesticides Control and Phytopharmacy, Laboratory of Pesticides' Toxicology, Kifissia, Athens, Greece, 2 Benaki Phytopathological Institute, Department of Phytopathology, Laboratory of Non-Parasitic Diseases, Kifissia, Athens, Greece * [email protected] (KMK); [email protected] (KM) Abstract a1111111111 Propolis is a bee product that has been extensively used in alternative medicine and recently a1111111111 a1111111111 has gained interest on a global scale as an essential ingredient of healthy foods and cosmet- a1111111111 ics. Propolis is also considered to improve human health and to prevent diseases such as a1111111111 inflammation, heart disease, diabetes and even cancer. However, the claimed effects are anticipated to be correlated to its chemical composition. Since propolis is a natural product, its composition is consequently expected to be variable depending on the local flora align- ment. In this work, we present the development of a novel HPLC-PDA-ESI/MS targeted OPEN ACCESS method, used to identify and quantify 59 phenolic compounds in Greek propolis hydroalco- holic extracts. Amongst them, nine phenolic compounds are herein reported for the first time Citation: Kasiotis KM, Anastasiadou P, Papadopoulos A, Machera K (2017) Revisiting in Greek propolis. Alongside GC-MS complementary analysis was employed, unveiling Greek Propolis: Chromatographic Analysis and eight additional newly reported compounds. The antioxidant activity study of the propolis Antioxidant Activity Study. PLoS ONE 12(1): samples verified the potential of these extracts to effectively scavenge radicals, with the e0170077. doi:10.1371/journal.pone.0170077 extract of Imathia region exhibiting comparable antioxidant activity to that of quercetin.
  • Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns

    Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns

    molecules Review Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns Johra Khan 1,†, Prashanta Kumar Deb 2,3,†, Somi Priya 4 , Karla Damián Medina 5, Rajlakshmi Devi 2, Sanjay G. Walode 6 and Mithun Rudrapal 6,*,† 1 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia; [email protected] 2 Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, Assam, India; [email protected] (P.K.D.); [email protected] (R.D.) 3 Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India 4 University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India; [email protected] 5 Food Technology Unit, Centre for Research and Assistance in Technology and Design of Jalisco State A.C., Camino Arenero 1227, El Bajío del Arenal, Zapopan 45019, Jalisco, Mexico; [email protected] 6 Rasiklal M. Dhariwal Institute of Pharmaceutical Education & Research, Chinchwad, Pune 411019, Maharashtra, India; [email protected] * Correspondence: [email protected]; Tel.: +91-8638724949 † These authors contributed equally to this work. Citation: Khan, J.; Deb, P.K.; Priya, S.; Medina, K.D.; Devi, R.; Walode, S.G.; Abstract: Flavonoids comprise a large group of structurally diverse polyphenolic compounds of Rudrapal, M. Dietary Flavonoids: plant origin and are abundantly found in human diet such as fruits, vegetables, grains, tea, dairy Cardioprotective Potential with products, red wine, etc. Major classes of flavonoids include flavonols, flavones, flavanones, flavanols, Antioxidant Effects and Their anthocyanidins, isoflavones, and chalcones. Owing to their potential health benefits and medicinal Pharmacokinetic, Toxicological and significance, flavonoids are now considered as an indispensable component in a variety of medicinal, Therapeutic Concerns.
  • Distribution of Flavonoids Among Malvaceae Family Members – a Review

    Distribution of Flavonoids Among Malvaceae Family Members – a Review

    Distribution of flavonoids among Malvaceae family members – A review Vellingiri Vadivel, Sridharan Sriram, Pemaiah Brindha Centre for Advanced Research in Indian System of Medicine (CARISM), SASTRA University, Thanjavur, Tamil Nadu, India Abstract Since ancient times, Malvaceae family plant members are distributed worldwide and have been used as a folk remedy for the treatment of skin diseases, as an antifertility agent, antiseptic, and carminative. Some compounds isolated from Malvaceae members such as flavonoids, phenolic acids, and polysaccharides are considered responsible for these activities. Although the flavonoid profiles of several Malvaceae family members are REVIEW REVIEW ARTICLE investigated, the information is scattered. To understand the chemical variability and chemotaxonomic relationship among Malvaceae family members summation of their phytochemical nature is essential. Hence, this review aims to summarize the distribution of flavonoids in species of genera namely Abelmoschus, Abroma, Abutilon, Bombax, Duboscia, Gossypium, Hibiscus, Helicteres, Herissantia, Kitaibelia, Lavatera, Malva, Pavonia, Sida, Theobroma, and Thespesia, Urena, In general, flavonols are represented by glycosides of quercetin, kaempferol, myricetin, herbacetin, gossypetin, and hibiscetin. However, flavonols and flavones with additional OH groups at the C-8 A ring and/or the C-5′ B ring positions are characteristic of this family, demonstrating chemotaxonomic significance. Key words: Flavones, flavonoids, flavonols, glycosides, Malvaceae, phytochemicals INTRODUCTION connate at least at their bases, but often forming a tube around the pistils. The pistils are composed of two to many connate he Malvaceae is a family of flowering carpels. The ovary is superior, with axial placentation, with plants estimated to contain 243 genera capitate or lobed stigma. The flowers have nectaries made with more than 4225 species.
  • BIOLOGICAL PROPERTIES of SELECTED FLAVONOIDS of ROOIBOS (Aspalathus Linearis)

    BIOLOGICAL PROPERTIES of SELECTED FLAVONOIDS of ROOIBOS (Aspalathus Linearis)

    BIOLOGICAL PROPERTIES OF SELECTED FLAVONOIDS OF ROOIBOS (Aspalathus linearis) Petra W Snijman Thesis presented in partial fulfilment of the requirements for the degree of Master of Science in Chemistry at the University of the Western Cape Study Leader: Prof IR Green Co-study Leaders: Prof E Joubert Prof WCA Gelderblom June 2007 ii DECLARATION I, the undersigned, hereby declare that the work contained in this thesis is my own original work and that I have not previously in its entirety or in part submitted it at any university for a degree. _______________________________ ____________ Petra Wilhelmina Snijman Date Copyright © 2007 University of the Western Cape All rights reserved iii ABSTRACT Bioactivity-guided fractionation was used to identify the most potent antioxidant and antimutagenic fractions contained in the methanol extract of unfermented rooibos (Aspalathus linearis), as well as the bioactive principles for the most potent antioxidant fractions. The different extracts and fractions were screened using Salmonella typhimurium tester strain TA98 and metabolically activated 2- acetoaminofluorene (2-AAF) to evaluate antimutagenic potential, while the antioxidant potency was assessed by two different in vitro assays, i.e. the inhibition of Fe(II) induced microsomal lipid peroxidation and the scavenging of the 2,2'- azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) radical cation. The most polar XAD fraction displayed the most protection against 2-AAF induced mutagenesis in TA98. Successive fractionation of the two XAD fractions
  • Download PDF (Inglês)

    Download PDF (Inglês)

    Revista Brasileira de Farmacognosia 26 (2016) 451–458 ww w.elsevier.com/locate/bjp Original Article Chemical profiles of traditional preparations of four South American Passiflora species by chromatographic and capillary electrophoretic techniques a,b,∗ a c Geison Modesti Costa , Andressa Córneo Gazola , Silvana Maria Zucolotto , b b a a Leonardo Castellanos , Freddy Alejandro Ramos , Flávio Henrique Reginatto , Eloir Paulo Schenkel a Programa de Pós-graduac¸ ão em Farmácia, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil b Departamento de Química, Universidad Nacional de Colombia, Bogotá, Colombia c Departamento de Farmácia, Centro de Ciências da Saúde, Universidade Federal do Rio Grande do Norte, Natal, RN, Brazil a b s t r a c t a r t i c l e i n f o Article history: Several species of the genus Passiflora are distributed all over South America, and many of these species Received 17 November 2015 are used in popular medicine, mainly as sedatives and tranquilizers. This study analyzes the chemical Accepted 23 February 2016 profile of extracts of four Passiflora species used in folk medicine, focusing on the flavonoids, alkaloids Available online 13 April 2016 and saponins. We employed simple and fast fingerprint analysis methods by high performance liquid chromatography, ultra performance liquid chromatography and capillary electrophoresis techniques. Keywords: The analysis led to the detection and identification of C-glycosylflavonoids in all the plant extracts, these Passiflora being the main constituents in P. tripartita var. mollissima and P. bogotensis. Saponins were observed C-glycosylflavonoids only in P. alata and P. quadrangularis, while harmane alkaloids were not detected in any of the analyzed Alkaloids HPLC extracts in concentrations higher than 0.0187 ppm, the detection limit determined for the UPLC method.